Outrageous that this was ever approved. They fail to mention the brain lesions, edema, and bleeding that this drug causes. They fail to mention that the average AD patient will be able to afford ongoing treatment of this drug due to its cost and likely won't help them anyway. Disgraceful. I hope they investigate all involved.